PPIDT00052
Drug Information
| Name | Interferon beta-1a |
|---|---|
| Sequence | MSYNLLGFLQRSSNFQCQKLLWQLNGRLEYCLKDRMNFDIPEEIKQLQQFQKEDAALTIYEMLQNIFAIFRQDSSSTGWNETIVENLLANVYHQINHLKTVLEEKLEKEDFTRGKLMSSLHLKRYYGRILHYLKAKEYSHCAWTIVRVEILRNFYFINRLTGYLRN |
| DrugBank_ID | DB00060 |
| Type | biotech |
| Indication | For treatment of relapsing/remitting multiple sclerosis, also for condyloma acuminatum |
Dosage Forms
| Form | Route | Strength |
|---|---|---|
| Injection | Intramuscular |
30 ug
|
| Injection, powder, for solution | Intramuscular |
30 MCG/0.5ML
|
| Injection, powder, for solution | Intramuscular |
30 mcg
|
| Injection, powder, lyophilized, for solution | Intramuscular |
30 ug/1mL
|
| Injection, solution | Intramuscular |
30 MCG/0.5ML
|
| Kit | Intramuscular |
|
| Powder, for solution | Intramuscular |
|
| Powder, for solution | Intramuscular |
60 mcg / mL
|
| Solution | Intramuscular |
30 MCG/0.5ML
|
| Solution | Intramuscular |
30 mcg / 0.5 mL
|
| Solution | Intramuscular |
30.000 mcg
|
| Injection | Intramuscular |
30 mcg/0.5ml
|
| Injection, solution | Intramuscular |
30 ug/0.5mL
|
| Solution | Intramuscular |
3000000 mcg
|
| Solution | Subcutaneous |
|
| Solution | Parenteral |
30 mcg
|
| Solution | Parenteral |
22.000 mcg
|
| Injection | Intramuscular |
22 MCG/0.5ML
|
| Injection, solution | Cutaneous; Parenteral |
|
| Injection, solution | Parenteral; Subcutaneous |
22 MCG
|
| Injection, solution | Parenteral; Subcutaneous |
44 MCG
|
| Injection, solution | Subcutaneous |
22 MCG
|
| Injection, solution | Subcutaneous |
22 ug/0.5mL
|
| Injection, solution | Subcutaneous |
22 ug/0.5ml
|
| Injection, solution | Subcutaneous |
44 MCG
|
| Injection, solution | Subcutaneous |
44 ug/0.5mL
|
| Injection, solution | Subcutaneous |
44 ug/0.5ml
|
| Injection, solution | Subcutaneous |
8.8 MCG
|
| Kit | Subcutaneous |
|
| Kit; liquid; powder | Intralesional; Subcutaneous |
|
| Kit; liquid; powder, for solution | Subcutaneous |
|
| Solution | Subcutaneous |
132 mcg / 1.5 mL
|
| Solution | Subcutaneous |
22 mcg / 0.5 mL
|
| Solution | Subcutaneous |
44 mcg / 0.5 mL
|
| Solution | Subcutaneous |
66 mcg / 1.5 mL
|
| Solution | Subcutaneous |
8.8 mcg / 0.2 mL
|
| Injection, solution | — |
22 mcg/0.5ml
|
| Injection, solution | — |
44 mcg/0.5ml
|
| Injection, solution | Subcutaneous |
132 mcg/1.5ml
|
| Solution | — |
22 mcg/0.5ml
|
| Injection, solution | Subcutaneous |
|
| Solution | — |
44 mcg/0.5ml
|
| Injection, solution | Subcutaneous |
66 mcg/1.5ml
|
| Solution | Subcutaneous |
66.000 ug
|
| Injection, solution | Subcutaneous |
22 mcg/0.5mL
|
| Injection, solution | Subcutaneous |
44 mcg/0.5mL
|
| Injection, powder, for solution | Intramuscular |
|
| Solution | Parenteral |
30.000 mcg
|
Target Information